Our mission is to reduce suffering and improve the general wellness of millions of patients with incontinent associated skin problems. A key part to achieving our mission is to establish Dynamic Oxygen Skin Therapy (DOST™) as the standard of care.
RashEndZ™, Inc. is the medical device start-up that patented the world’s first non-occludable, non-cloggable skin aeration technology, RashEndZ™, for the millions of people suffering from incontinence. REZair™ is the first product which will utilize such technology. REZair™ connects to any consumer respiratory air or oxygen source, and circulates it directly to the adult or child’s garment/diaper-covered skin. This results in significant improvement in incontinent skin health for all patients. This new therapy, Dynamic Oxygen Skin Therapy (DOST™), delivers the soothing comfort of continuous wetness reduction and increased oxygenation of the skin, day or night.